State government links sponsors, sites and CROs in Australia

By Flora Southey contact

- Last updated on GMT

GettyImages/s-c-s
GettyImages/s-c-s
An online portal designed to connect sponsors with trial sites and contract research organizations has been launched by the Victorian state government in Australia.

The Victorian Clinical Trials Gateway offers a single point of entry for global companies looking to access Victoria’s universities, independent medical research institutes, clinical trial networks, biobanks and contract research organizations (CROs).

According to the government, the initiative – which responds to the growing number of trials conducted in the state – will also help local start-ups and small to medium-sized companies find support and services to attract business. 

Global companies are increasingly outsourcing their early phase clinical trials to Melbourne for three reasons: cost-efficiency, speed, and quality, said a spokesperson from the state’s department of economic development, jobs, transport and resourcing. 

“Australia offers attractive R&D tax incentives, including cash rebates,” ​she told us. 

In 2016, Outsourcing-Pharma reported​ that Australia’s tax incentive program make clinical trials up to 60% more cost-effective compared to US-based trials.  

Additionally, the state – which we were told is estimated to provide around a third of Australia’s clinical trial sites – is home to “key niche CROs” ​such as Nucleus Network, Neuroscience Trials Australia, and Cancer Trials Australia, said the spokesperson.

“Based on our expertise in treating diseases like cancer, and our large-scale infrastructure like the Victorian Comprehensive Cancer Centre, we understand that the majority of commercially sponsored cancer trials run in Australia have trial sites in Victoria,” ​she added.

According to the spokesperson, Victoria’s clinical trial process also “saves time and money by avoiding duplication and allowing flexibility without compromising quality.”

Related topics: Clinical Development, Phase I-II

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars